Related Experiment Video
Updated: Feb 6, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Digital twins for accelerating drug discovery and development: opportunities and challenges
Sai Phanindra Venkatapurapu1, Lindsay Clegg1, Andrzej Nowojewski2
1Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD 20878, USA.
Abstract:
Digital twins can revolutionize drug development and personalized care by accelerating timelines, reducing costs and failure rates, and potentially improving the safety and efficacy of new therapies. In this review, we explore different applications of digital twins across the pharmaceutical value chain, from target discovery and preclinical research to clinical trials, regulatory review, manufacturing and post-market clinical practice. Key challenges, however, remain in data integration, model reliability, regulatory acceptance and data privacy. Overcoming these barriers will require innovation, transparency and collaborative efforts across the healthcare ecosystem to fully realize digital twin potential for patients, healthcare providers and the pharmaceutical industry.
More Related Videos
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Drug Discovery: Overview
Accelerators
The effectiveness of calcium chloride can...
Average Acceleration
Instantaneous Acceleration
Acceleration Vectors
Accelerating Fluids
The motion of the liquid within this infinitesimal cylinder is considered to obtain the pressure difference. Three vertical forces act on this liquid: